New Gene Responsible for Resistance of Clinical Corynebacteria to Macrolide, Lincosamide and Streptogramin B

Pol J Microbiol. 2018 Jun 30;67(2):237-240. doi: 10.21307/pjm-2018-028.

Abstract

The subject of the study was phenotypic marking of the antibiotic susceptibility and MLSB resistance mechanism in Corynebacterium spp. isolated from human skin (18 isolates) and from clinical materials (19 isolates). The strains were tested for the presence of the erm(A), erm(B), erm(C), erm(X), lnu(A), msr(A), msr(B) and mph(C) genes. Clinical isolates showed wide resistance to antibiotics. In 89% clinical isolates and 72% skin microbiota a constitutive type of MLSB resistance was found. In 12 clinical isolates the erm(C) gene was detected-eight of which had erm(X) as well as erm(C), two harboured erm(X), erm(C) and erm(A) and two demonstrated only erm(C).

Keywords: Corynebacterium spp.; MLSB; erm(C); resistance genes.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / genetics
  • Corynebacterium / drug effects*
  • Corynebacterium / genetics*
  • Corynebacterium Infections / microbiology
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Humans
  • Lincosamides / pharmacology*
  • Macrolides / pharmacology*
  • Male
  • Microbial Sensitivity Tests
  • Skin / microbiology
  • Streptogramin B / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Lincosamides
  • Macrolides
  • Streptogramin B